“脊髓性肌萎缩症康复管理”专家第二次研讨会于线上顺利举办

2022-02-23 MedSci原创 MedSci原创

脊髓性肌萎缩症(SMA)是由于运动神经元存活基因1(SMN1)缺失或突变导致功能性SMN蛋白不足而引起的一种常染色体隐性遗传性疾病,主要临床特征为肌无力和肌萎缩。

脊髓性肌萎缩症(SMA)是由于运动神经元存活基因1(SMN1)缺失或突变导致功能性SMN蛋白不足而引起的一种常染色体隐性遗传性疾病,主要临床特征为肌无力和肌萎缩,常危及全身多个系统,可致死致残[1, 2]康复管理是治疗SMA疾病的重要手段。研究表明,积极的康复管理,如规律的运动训练、应用矫形器等可以延缓SMA的疾病进展、预防并发症,还能为患者的心理健康和生活质量带来有利影响[3, 4]今年6月份中国国家药品监督管理局通过优先审评审批程序批准首个治疗SMA的口服药物利司扑兰(Risdiplam)上市,为SMA患者提供了全新的治疗选择。随着这些药物的临床应用,SMA患者的整体功能得到改善,康复科医生将在SMA患者的全程管理中发挥更为重要的角色。

 

为规范我国康复科医生对SMA患者的康复评估和治疗,从而提高SMA患者的整体功能和生活质量。2021年12月15日,中华医学会儿科分会康复学组组织的“脊髓性肌萎缩症康复管理”专家第二次研讨会采用网络在线方式召开。国内来自康复科、神经科等多个领域的28位权威专家参与,就我国SMA患者的功能评估、康复目标和康复建议等内容进行了深入探讨。

 

会议由广州市妇女儿童医疗中心徐开寿教授主持。会议开始,重庆医科大学附属儿童医院肖农教授对各位与会专家表达了感谢,并就第一次研讨会后各位专家所做出的工作给予了充分肯定。随后,徐开寿教授就本次研讨会的召开背景和主要议题进行了介绍,并依次邀请各位专家发表自己的观点和看法。

会议讨论环节。各位专家首先就运动功能评估量表的适用范围发表了自己的意见,多数专家认为,随着药物的临床应用,SMA患者的运动功能发生变化,目前临床常用的量表,如CHOP INTEND、HFMSE和RULM等适用的SMA功能状态应该放宽,不应限定年龄范围。但有的专家认为,限定年龄范围更有利于指导临床。关于康复目标,各位专家的观点都趋于一致,即基于SMA患者的功能状态制定不同的康复目标,如不能独坐者由于多数时间处于卧位,康复治疗的目标应为改善功能、减轻障碍、优化不同体位的耐受性等。在康复建议上,有专家认为,SMA患者应减少石膏固定,因为会加重肌肉萎缩和肌肉负荷,但也有一些骨科大夫支持石膏固定。关于吞咽训练,有专家建议加入体位管理,即进食体位保持30°卧位的角度。除此之外,各位专家还针对SMA的远程康复指导、用药期间的监测指标、运动训练的耐受情况等展开了讨论。

这次会上,各位专家特别强调了人文关怀,即在SMA的康复训练过程中要时刻关注孩子的疲劳情况,避免运动过量。在称呼上,有专家建议把原来不能独坐、能独坐、能独走的称呼修改为卧者、坐着和行者,以体现对SMA孩子的关怀和爱意。会议最后,由肖农教授徐开寿教授进行总结发言,对各位专家的精彩致辞和宝贵建议表示感谢,相信在各位专家的共同努力下,SMA患者的康复管理将更加规范、完善。

 

参考文献:

[1] Mercuri E, Finkel RS, Muntoni F, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care [J]. Neuromuscul Disord, 2018, 28: 103-115. Doi: 10.1016/j.nmd.2017.11.005.

[2] Nash LA, Burns JK, Chardon JW, et al. Spinal Muscular Atrophy: More than a Disease of Motor Neurons? [J]. Curr Mol Med, 2016, 16: 779-792. Doi: 10.2174/1566524016666161128113338.

[3] Bora G, Subaşı-Yıldız Ş, Yeşbek-Kaymaz A, et al. Effects of Arm Cycling Exercise in Spinal Muscular Atrophy Type II Patients: A Pilot Study [J]. J Child Neurol, 2018, 33: 209-215. Doi: 10.1177/0883073817750500.

[4] Lewelt A, Krosschell KJ, Stoddard GJ, et al. Resistance strength training exercise in children with spinal muscular atrophy [J]. Muscle Nerve, 2015, 52: 559-567. Doi: 10.1002/mus.24568.

病,主要临床特征为肌无力和肌萎缩,常危及全身多个系统,可致死致残[1, 2]

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1994865, encodeId=b071199486542, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Nov 17 07:59:40 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696039, encodeId=57dd1696039ca, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Wed Jan 11 10:59:40 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723531, encodeId=9bb71e2353190, content=<a href='/topic/show?id=3e238460e7e' target=_blank style='color:#2F92EE;'>#脊髓性肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84607, encryptionId=3e238460e7e, topicName=脊髓性肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901033462428, createdName=soongzhihua, createdTime=Mon Sep 05 09:59:40 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503193, encodeId=609f15031936b, content=<a href='/topic/show?id=a71481058ca' target=_blank style='color:#2F92EE;'>#肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81058, encryptionId=a71481058ca, topicName=肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eebd9606217, createdName=neizongke, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514499, encodeId=0cde1514499bd, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8810654266, createdName=more is better!, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196712, encodeId=31121196e123d, content=学到了很多东西,谢谢各位老师的指导, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Thu Feb 24 09:37:48 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196487, encodeId=ccc4119648e5d, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Feb 23 18:13:19 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196470, encodeId=2ddb11964e01e, content=1111, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196469, encodeId=9c311196469fe, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:41 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196466, encodeId=498f1196466f2, content=。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:48:24 CST 2022, time=2022-02-23, status=1, ipAttribution=)]
    2022-11-17 kcb069
  2. [GetPortalCommentsPageByObjectIdResponse(id=1994865, encodeId=b071199486542, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Nov 17 07:59:40 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696039, encodeId=57dd1696039ca, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Wed Jan 11 10:59:40 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723531, encodeId=9bb71e2353190, content=<a href='/topic/show?id=3e238460e7e' target=_blank style='color:#2F92EE;'>#脊髓性肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84607, encryptionId=3e238460e7e, topicName=脊髓性肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901033462428, createdName=soongzhihua, createdTime=Mon Sep 05 09:59:40 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503193, encodeId=609f15031936b, content=<a href='/topic/show?id=a71481058ca' target=_blank style='color:#2F92EE;'>#肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81058, encryptionId=a71481058ca, topicName=肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eebd9606217, createdName=neizongke, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514499, encodeId=0cde1514499bd, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8810654266, createdName=more is better!, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196712, encodeId=31121196e123d, content=学到了很多东西,谢谢各位老师的指导, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Thu Feb 24 09:37:48 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196487, encodeId=ccc4119648e5d, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Feb 23 18:13:19 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196470, encodeId=2ddb11964e01e, content=1111, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196469, encodeId=9c311196469fe, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:41 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196466, encodeId=498f1196466f2, content=。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:48:24 CST 2022, time=2022-02-23, status=1, ipAttribution=)]
    2023-01-11 chendoc252
  3. [GetPortalCommentsPageByObjectIdResponse(id=1994865, encodeId=b071199486542, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Nov 17 07:59:40 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696039, encodeId=57dd1696039ca, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Wed Jan 11 10:59:40 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723531, encodeId=9bb71e2353190, content=<a href='/topic/show?id=3e238460e7e' target=_blank style='color:#2F92EE;'>#脊髓性肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84607, encryptionId=3e238460e7e, topicName=脊髓性肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901033462428, createdName=soongzhihua, createdTime=Mon Sep 05 09:59:40 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503193, encodeId=609f15031936b, content=<a href='/topic/show?id=a71481058ca' target=_blank style='color:#2F92EE;'>#肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81058, encryptionId=a71481058ca, topicName=肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eebd9606217, createdName=neizongke, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514499, encodeId=0cde1514499bd, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8810654266, createdName=more is better!, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196712, encodeId=31121196e123d, content=学到了很多东西,谢谢各位老师的指导, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Thu Feb 24 09:37:48 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196487, encodeId=ccc4119648e5d, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Feb 23 18:13:19 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196470, encodeId=2ddb11964e01e, content=1111, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196469, encodeId=9c311196469fe, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:41 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196466, encodeId=498f1196466f2, content=。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:48:24 CST 2022, time=2022-02-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1994865, encodeId=b071199486542, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Nov 17 07:59:40 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696039, encodeId=57dd1696039ca, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Wed Jan 11 10:59:40 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723531, encodeId=9bb71e2353190, content=<a href='/topic/show?id=3e238460e7e' target=_blank style='color:#2F92EE;'>#脊髓性肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84607, encryptionId=3e238460e7e, topicName=脊髓性肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901033462428, createdName=soongzhihua, createdTime=Mon Sep 05 09:59:40 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503193, encodeId=609f15031936b, content=<a href='/topic/show?id=a71481058ca' target=_blank style='color:#2F92EE;'>#肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81058, encryptionId=a71481058ca, topicName=肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eebd9606217, createdName=neizongke, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514499, encodeId=0cde1514499bd, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8810654266, createdName=more is better!, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196712, encodeId=31121196e123d, content=学到了很多东西,谢谢各位老师的指导, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Thu Feb 24 09:37:48 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196487, encodeId=ccc4119648e5d, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Feb 23 18:13:19 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196470, encodeId=2ddb11964e01e, content=1111, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196469, encodeId=9c311196469fe, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:41 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196466, encodeId=498f1196466f2, content=。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:48:24 CST 2022, time=2022-02-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1994865, encodeId=b071199486542, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Nov 17 07:59:40 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696039, encodeId=57dd1696039ca, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Wed Jan 11 10:59:40 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723531, encodeId=9bb71e2353190, content=<a href='/topic/show?id=3e238460e7e' target=_blank style='color:#2F92EE;'>#脊髓性肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84607, encryptionId=3e238460e7e, topicName=脊髓性肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901033462428, createdName=soongzhihua, createdTime=Mon Sep 05 09:59:40 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503193, encodeId=609f15031936b, content=<a href='/topic/show?id=a71481058ca' target=_blank style='color:#2F92EE;'>#肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81058, encryptionId=a71481058ca, topicName=肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eebd9606217, createdName=neizongke, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514499, encodeId=0cde1514499bd, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8810654266, createdName=more is better!, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196712, encodeId=31121196e123d, content=学到了很多东西,谢谢各位老师的指导, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Thu Feb 24 09:37:48 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196487, encodeId=ccc4119648e5d, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Feb 23 18:13:19 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196470, encodeId=2ddb11964e01e, content=1111, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196469, encodeId=9c311196469fe, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:41 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196466, encodeId=498f1196466f2, content=。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:48:24 CST 2022, time=2022-02-23, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1994865, encodeId=b071199486542, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Nov 17 07:59:40 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696039, encodeId=57dd1696039ca, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Wed Jan 11 10:59:40 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723531, encodeId=9bb71e2353190, content=<a href='/topic/show?id=3e238460e7e' target=_blank style='color:#2F92EE;'>#脊髓性肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84607, encryptionId=3e238460e7e, topicName=脊髓性肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901033462428, createdName=soongzhihua, createdTime=Mon Sep 05 09:59:40 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503193, encodeId=609f15031936b, content=<a href='/topic/show?id=a71481058ca' target=_blank style='color:#2F92EE;'>#肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81058, encryptionId=a71481058ca, topicName=肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eebd9606217, createdName=neizongke, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514499, encodeId=0cde1514499bd, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8810654266, createdName=more is better!, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196712, encodeId=31121196e123d, content=学到了很多东西,谢谢各位老师的指导, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Thu Feb 24 09:37:48 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196487, encodeId=ccc4119648e5d, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Feb 23 18:13:19 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196470, encodeId=2ddb11964e01e, content=1111, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196469, encodeId=9c311196469fe, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:41 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196466, encodeId=498f1196466f2, content=。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:48:24 CST 2022, time=2022-02-23, status=1, ipAttribution=)]
    2022-02-24 1436749007

    学到了很多东西,谢谢各位老师的指导

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1994865, encodeId=b071199486542, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Nov 17 07:59:40 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696039, encodeId=57dd1696039ca, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Wed Jan 11 10:59:40 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723531, encodeId=9bb71e2353190, content=<a href='/topic/show?id=3e238460e7e' target=_blank style='color:#2F92EE;'>#脊髓性肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84607, encryptionId=3e238460e7e, topicName=脊髓性肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901033462428, createdName=soongzhihua, createdTime=Mon Sep 05 09:59:40 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503193, encodeId=609f15031936b, content=<a href='/topic/show?id=a71481058ca' target=_blank style='color:#2F92EE;'>#肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81058, encryptionId=a71481058ca, topicName=肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eebd9606217, createdName=neizongke, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514499, encodeId=0cde1514499bd, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8810654266, createdName=more is better!, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196712, encodeId=31121196e123d, content=学到了很多东西,谢谢各位老师的指导, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Thu Feb 24 09:37:48 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196487, encodeId=ccc4119648e5d, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Feb 23 18:13:19 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196470, encodeId=2ddb11964e01e, content=1111, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196469, encodeId=9c311196469fe, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:41 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196466, encodeId=498f1196466f2, content=。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:48:24 CST 2022, time=2022-02-23, status=1, ipAttribution=)]
    2022-02-23 yangchou

    好文章,谢谢分享。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1994865, encodeId=b071199486542, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Nov 17 07:59:40 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696039, encodeId=57dd1696039ca, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Wed Jan 11 10:59:40 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723531, encodeId=9bb71e2353190, content=<a href='/topic/show?id=3e238460e7e' target=_blank style='color:#2F92EE;'>#脊髓性肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84607, encryptionId=3e238460e7e, topicName=脊髓性肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901033462428, createdName=soongzhihua, createdTime=Mon Sep 05 09:59:40 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503193, encodeId=609f15031936b, content=<a href='/topic/show?id=a71481058ca' target=_blank style='color:#2F92EE;'>#肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81058, encryptionId=a71481058ca, topicName=肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eebd9606217, createdName=neizongke, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514499, encodeId=0cde1514499bd, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8810654266, createdName=more is better!, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196712, encodeId=31121196e123d, content=学到了很多东西,谢谢各位老师的指导, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Thu Feb 24 09:37:48 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196487, encodeId=ccc4119648e5d, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Feb 23 18:13:19 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196470, encodeId=2ddb11964e01e, content=1111, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196469, encodeId=9c311196469fe, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:41 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196466, encodeId=498f1196466f2, content=。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:48:24 CST 2022, time=2022-02-23, status=1, ipAttribution=)]
    2022-02-23 ms1000001191450835

    1111

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1994865, encodeId=b071199486542, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Nov 17 07:59:40 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696039, encodeId=57dd1696039ca, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Wed Jan 11 10:59:40 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723531, encodeId=9bb71e2353190, content=<a href='/topic/show?id=3e238460e7e' target=_blank style='color:#2F92EE;'>#脊髓性肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84607, encryptionId=3e238460e7e, topicName=脊髓性肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901033462428, createdName=soongzhihua, createdTime=Mon Sep 05 09:59:40 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503193, encodeId=609f15031936b, content=<a href='/topic/show?id=a71481058ca' target=_blank style='color:#2F92EE;'>#肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81058, encryptionId=a71481058ca, topicName=肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eebd9606217, createdName=neizongke, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514499, encodeId=0cde1514499bd, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8810654266, createdName=more is better!, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196712, encodeId=31121196e123d, content=学到了很多东西,谢谢各位老师的指导, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Thu Feb 24 09:37:48 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196487, encodeId=ccc4119648e5d, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Feb 23 18:13:19 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196470, encodeId=2ddb11964e01e, content=1111, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196469, encodeId=9c311196469fe, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:41 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196466, encodeId=498f1196466f2, content=。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:48:24 CST 2022, time=2022-02-23, status=1, ipAttribution=)]
    2022-02-23 ms1000001191450835

    。。。。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1994865, encodeId=b071199486542, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Nov 17 07:59:40 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696039, encodeId=57dd1696039ca, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Wed Jan 11 10:59:40 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723531, encodeId=9bb71e2353190, content=<a href='/topic/show?id=3e238460e7e' target=_blank style='color:#2F92EE;'>#脊髓性肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84607, encryptionId=3e238460e7e, topicName=脊髓性肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901033462428, createdName=soongzhihua, createdTime=Mon Sep 05 09:59:40 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503193, encodeId=609f15031936b, content=<a href='/topic/show?id=a71481058ca' target=_blank style='color:#2F92EE;'>#肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81058, encryptionId=a71481058ca, topicName=肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eebd9606217, createdName=neizongke, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514499, encodeId=0cde1514499bd, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8810654266, createdName=more is better!, createdTime=Fri Feb 25 06:59:40 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196712, encodeId=31121196e123d, content=学到了很多东西,谢谢各位老师的指导, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Thu Feb 24 09:37:48 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196487, encodeId=ccc4119648e5d, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Feb 23 18:13:19 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196470, encodeId=2ddb11964e01e, content=1111, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196469, encodeId=9c311196469fe, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:49:41 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196466, encodeId=498f1196466f2, content=。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:48:24 CST 2022, time=2022-02-23, status=1, ipAttribution=)]
    2022-02-23 ms1000001191450835

    。。。。。

    0

相关资讯

IQVIA艾昆纬和百度健康在罕见病领域达成战略合作 构建以患者为中心的数字化解决方案--正本清源 缩短患者旅程

IQVIA艾昆纬(下简称“IQVIA”)和百度健康正式达成战略合作,基于罕见病患者全就诊旅程的痛点,以价值医疗为导向,为患者提供一站式的数字化解决方案。

从常规血气到代谢再到基因检测,罕见病例快速、精准检验全过程

临床上常规生化等检测难以对MCD确诊,常需要检测氨基酸和酰基肉碱谱联合尿液有机酸谱对MCD进行筛查诊断。

NEJM:这种10岁前就会死亡的罕见病,被慢病毒基因疗法修复了

Hurler综合征,也叫粘多糖病I-H型,是一种罕见的常染色体隐性遗传病。由于基因突变导致α-L-艾杜糖醛酸苷酶(IDUA)缺乏,进而导致粘多糖分解受阻,在体内堆积。是粘多糖病中最常见和最严重的类型。

罕见病临床试验挑战与研究设计方法(梅斯医学)

目前有7000-8000种已知的罕见疾病,尽管在过去20年中与罕见病相关的研究已经有了很大的进展,但绝大多数罕见病还未获得批准治疗方法。研究人员研发罕见病治疗药物面临包括临床试验设计和临床试验有效开展